Mylan Institutional is a new customer-focused business providing a differentiated basket of pharmaceutical products and services to institutional customers, which include group purchasing organizations, wholesalers, hospitals, surgical and radiology services, home infusion service providers, long-term care facilities, correctional facilities, specialty pharmacies, veterinary clinics and retail outlets.
Mylan Institutional’s product offering combines the injectables of Bioniche Pharma with the leading unit dose capabilities of UDL Laboratories. The offering includes approximately 60 injectable products and approximately 500 SKUs in unit dose, unit-of-use and automation-ready package formats (as of September 2012).
Bioniche Pharma provides a broad range and reliable supply of high quality, difficult-to-formulate or difficult-to-manufacture injectable products. UDL brings product packaging innovations that help reduce dispensing errors, increase efficiency and improve patient care. Together, Bioniche Pharma and UDL – as Mylan Institutional – form one powerful and customer-centric offering to the institutional health care market.
View the complete Fact Sheet and download or print copies by clicking the links below.
Click here for Letter Size.